Author: Editorial Team

ALPHARETTA, Ga., Feb. 20, 2025 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), reported that Arctic Vision’s New Drug Application (NDA) for ARCATUS® for the treatment of uveitic macular edema (UME) has been formally accepted for review by the Center for Drug Evaluation of China National Medical Products Administration.Read More

Read More

HELSINKI (Reuters) – The European Commission will propose at least five packages this year to ease digital regulation, European Commission Vice President Henna Virkkunen said on Thursday. “I personally think that we have too much of a heavy administrative burden and bureaucracy,” Virkkunen, the EU …Read More

Read More